<DOC>
	<DOCNO>NCT00048048</DOCNO>
	<brief_summary>This study evaluate efficacy safety different subcutaneous start dos dose frequency Mircera anemic patient chronic kidney disease yet dialysis . The anticipated time study treatment 3-12 month target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Study Mircera Anemic Patients With Chronic Kidney Disease Not Yet Dialysis .</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>adult patient &gt; =18 year age ; chronic renal anemia ; receive renal replacement therapy . woman pregnant , breastfeed use unreliable birth control method ; administration investigational drug within 30 day precede screen visit runin period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>